315 related articles for article (PubMed ID: 20109651)
1. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
Bevan DH
Thromb Res; 2009 Dec; 124 Suppl 2():S12-6. PubMed ID: 20109651
[TBL] [Abstract][Full Text] [Related]
2. A critical evaluation of cryoprecipitate for replacement of fibrinogen.
Sørensen B; Bevan D
Br J Haematol; 2010 Jun; 149(6):834-43. PubMed ID: 20456356
[TBL] [Abstract][Full Text] [Related]
3. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency.
Peyvandi F
Thromb Res; 2009 Dec; 124 Suppl 2():S9-11. PubMed ID: 20109654
[TBL] [Abstract][Full Text] [Related]
4. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen.
Haverkate F; Samama M
Thromb Haemost; 1995 Jan; 73(1):151-61. PubMed ID: 7740487
[TBL] [Abstract][Full Text] [Related]
5. Congenital Fibrinogen Deficiency in India and Role of Human Fibrinogen Concentrate.
John MJ; Byreddy P; Modak K; Makkar M
Acta Haematol; 2021; 144(6):595-602. PubMed ID: 34091452
[TBL] [Abstract][Full Text] [Related]
6. Rare inherited disorders of fibrinogen.
Acharya SS; Dimichele DM
Haemophilia; 2008 Nov; 14(6):1151-8. PubMed ID: 19141154
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and treatment of congenital fibrinogen deficiency.
Peyvandi F
Thromb Res; 2012 Dec; 130 Suppl 2():S7-11. PubMed ID: 23439004
[TBL] [Abstract][Full Text] [Related]
8. Congenital fibrinogen disorders: an update.
de Moerloose P; Casini A; Neerman-Arbez M
Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822
[TBL] [Abstract][Full Text] [Related]
9. Congenital fibrinogen disorders.
de Moerloose P; Neerman-Arbez M
Semin Thromb Hemost; 2009 Jun; 35(4):356-66. PubMed ID: 19598064
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of congenital fibrinogen disorders.
Lebreton A; Casini A
Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693
[TBL] [Abstract][Full Text] [Related]
11. [Congenital afibrinogenemia with bleeding, bone cysts and antibodies to fibrinogen].
Ra'anani P; Levi Y; Varon D; Gitel S; Martinowitz U
Harefuah; 1991 Nov; 121(9):291-3. PubMed ID: 1800275
[TBL] [Abstract][Full Text] [Related]
12. Two novel mutations in the fibrinogen γ nodule.
Kotlín R; Pastva O; Stikarová J; Hlaváčková A; Suttnar J; Chrastinová L; Riedel T; Salaj P; Dyr JE
Thromb Res; 2014 Oct; 134(4):901-8. PubMed ID: 25074738
[TBL] [Abstract][Full Text] [Related]
13. Laboratory testing for fibrinogen abnormalities.
Verhovsek M; Moffat KA; Hayward CP
Am J Hematol; 2008 Dec; 83(12):928-31. PubMed ID: 18951466
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy.
Miesbach W; Galanakis D; Scharrer I
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502
[TBL] [Abstract][Full Text] [Related]
15. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis.
Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K
Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446
[TBL] [Abstract][Full Text] [Related]
16. Congenital afibrinogenemia.
al-Mondhiry H; Ehmann WC
Am J Hematol; 1994 Aug; 46(4):343-7. PubMed ID: 8037188
[TBL] [Abstract][Full Text] [Related]
17. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
Kotlín R; Suttnar J; Cápová I; Hrachovinová I; Urbánková M; Dyr JE
Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
[TBL] [Abstract][Full Text] [Related]
18. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens.
Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N
Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of fibrinogen deficiency.
Neerman-Arbez M
Pathophysiol Haemost Thromb; 2006; 35(1-2):187-98. PubMed ID: 16855369
[TBL] [Abstract][Full Text] [Related]
20. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications.
Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H
Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
